Study S002026

Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers in Women With Obesity and Other Risk Factors for Breast Cancer

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06485089
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 25
Start: 2024-09-14
Primary completion: 2026-03-25
Lead sponsor: University of Kansas Medical Center
Conditions: Obesity; Breast Cancer Risk
Interventions: DRUG:tirzepatide
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Feasibility of design as assessed by accrual rate of 1 or more per month over 12 months [12 months]
Completion rate of 70% or more [6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.